Dorman Products Reports Q1 Results, Reaffirms 2026 Guidance, and Executes Significant Share Buyback
summarizeSummary
Dorman Products reported mixed first-quarter results with sales growth but a significant EPS decline due to anticipated tariff impacts, while reaffirming its full-year 2026 guidance and repurchasing $51 million in shares.
check_boxKey Events
-
Q1 2026 Financial Results
Net sales increased 4.2% year-over-year to $528.8 million. Diluted EPS fell 24% to $1.43, and adjusted diluted EPS decreased 22% to $1.57, primarily due to the anticipated impact of higher tariff costs.
-
2026 Guidance Reaffirmed
The company reiterated its full-year 2026 guidance for net sales growth of 7-9% and adjusted diluted EPS of $8.10-$8.50, indicating performance is on track with management's expectations despite the Q1 EPS decline.
-
Significant Share Repurchase
Dorman repurchased $51 million of its common stock at an average price of $118 per share during the quarter. This represents a substantial return of capital to shareholders and a vote of confidence from management.
auto_awesomeAnalysis
The filing provides an update on Dorman Products' financial performance, confirming the anticipated impact of higher tariff costs on earnings per share, which was a known risk from the prior 10-K. Despite a 24% drop in diluted EPS, the company's 4.2% net sales growth and reaffirmed full-year guidance suggest performance is in line with management's adjusted expectations. The substantial $51 million share repurchase, representing approximately 1.5% of the market cap, demonstrates management's confidence and commitment to returning capital to shareholders, offsetting some of the negative sentiment from the earnings decline. Investors should monitor future reports for continued tariff impacts and the effectiveness of the company's strategies to mitigate these costs.
At the time of this filing, DORM was trading at $110.85 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $98.45 to $166.89. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.